Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aurinia Pharmaceuticals Inc. (AUPH)

9.51   -0.06 (-0.63%) 03-17 16:00
Open: 9.48 Pre. Close: 9.57
High: 9.7799 Low: 9.36
Volume: 2,483,946 Market Cap: 1,356(M)

Technical analysis

as of: 2023-03-20 8:44:15 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 12.18     One year: 14.22
Support: Support1: 8.65    Support2: 7.55
Resistance: Resistance1: 10.43    Resistance2: 12.18
Pivot: 9.18
Moving Average: MA(5): 9.38     MA(20): 8.9
MA(100): 6.97     MA(250): 8.66
MACD: MACD(12,26): 0.3     Signal(9): 0.3
Stochastic oscillator: %K(14,3): 63     %D(3): 61.4
RSI: RSI(14): 58.9
52-week: High: 13.41  Low: 4.07
Average Vol(K): 3-Month: 3,187 (K)  10-Days: 3,245 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ AUPH ] has closed below upper band by 28.7%. Bollinger Bands are 36.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.79 - 9.84 9.84 - 9.87
Low: 9.24 - 9.31 9.31 - 9.35
Close: 9.42 - 9.51 9.51 - 9.58

Company Description

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Headline News

Sun, 19 Mar 2023
Validea's Top Ten Healthcare Stocks Based On Warren Buffett - 3/19 ... - Nasdaq

Tue, 14 Mar 2023
Aurinia Pharmaceuticals Inc. (AUPH) Stock Observes 15.08% 200 ... - The News Heater

Mon, 13 Mar 2023
Is Aurinia Pharmaceuticals Inc (AUPH) Stock at the Top of the Biotechnology Industry? - InvestorsObserver

Thu, 09 Mar 2023
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript - Yahoo Finance

Wed, 08 Mar 2023
Trade Alert: The Independent Chairman of the Board Of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), George Milne, Has Just Spent US$178k Buying 40% More Shares - Simply Wall St

Tue, 07 Mar 2023
Will Aurinia Pharmaceuticals Inc (AUPH) Beat the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 143 (M)
Shares Float 140 (M)
% Held by Insiders 6.9 (%)
% Held by Institutions 38.3 (%)
Shares Short 14,960 (K)
Shares Short P.Month 11,030 (K)

Stock Financials

EPS -0.77
EPS Est Next Qtl -0.11
EPS Est This Year -1.01
EPS Est Next Year -0.39
Book Value (p.s.) 2.84
Profit Margin (%) -80.8
Operating Margin (%) -83.2
Return on Assets (ttm) -13.8
Return on Equity (ttm) -24.5
Qtrly Rev. Growth 21.5
Gross Profit (p.s.) 0.58
Sales Per Share 0.94
EBITDA (p.s.) -0.77
Qtrly Earnings Growth 0
Operating Cash Flow -80 (M)
Levered Free Cash Flow -35 (M)

Stock Valuations

PE Ratio -12.36
PEG Ratio 0
Price to Book value 3.33
Price to Sales 10.11
Price to Cash Flow -17.05

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.